| XLS |
|
Equity capital |
Reserves |
|
|
|||
€ million |
General |
Subscribed |
Capital |
Retained |
Gains/losses |
Minority |
Total |
Balance as of January 1, 2008 |
397.2 |
168.0 |
3,813.5 |
4,897.5 |
–650.5 |
61.9 |
8,687.6 |
Profit after tax |
– |
– |
– |
367.1 |
– |
12.0 |
379.1 |
Dividend payments |
– |
– |
– |
–206.8 |
– |
–5.7 |
–212.5 |
Profit transfers to/from E. Merck KG including transfers to reserves |
– |
– |
– |
–239.9 |
– |
– |
–239.9 |
Capital increase due to the exercise of stock options |
– |
– |
0.2 |
– |
– |
– |
0.2 |
Other changes in equity |
– |
– |
– |
– |
958.8 |
–8.3 |
950.5 |
Changes in scope of consolidation/Other |
– |
– |
– |
0.3 |
– |
–2.3 |
–2.0 |
Balance as of December 31, 2008 |
397.2 |
168.0 |
3,813.7 |
4,818.2 |
308.3 |
57.6 |
9,563.0 |
|
|
|
|
|
|
|
|
Balance as of January 1, 2009 |
397.2 |
168.0 |
3,813.5 |
4,818.2 |
308.3 |
57.6 |
9,563.0 |
Profit after tax |
– |
– |
– |
366.3 |
– |
10.4 |
376.7 |
Dividend payments |
– |
– |
– |
–96.9 |
– |
–7.9 |
–104.8 |
Profit transfers to/from E. Merck KG including transfers to reserves |
– |
– |
– |
–177.8 |
– |
– |
–177.8 |
Other changes in equity |
– |
– |
– |
– |
–136.1 |
–4.6 |
–140.7 |
Changes in scope of consolidation/Other |
– |
– |
– |
–0.2 |
–0.6 |
–2.0 |
–2.8 |
Balance as of December 31, 2009 |
397.2 |
168.0 |
3,813.7 |
4,909.6 |
171.6 |
53.5 |
9,513.6 |